Muscarinic and Nicotinic Symptoms in Organophosphate Poisoning
Organophosphate poisoning produces distinct muscarinic and nicotinic symptoms due to acetylcholinesterase inhibition and subsequent acetylcholine accumulation at different receptor sites. 1
Muscarinic Symptoms (Parasympathetic Effects)
Muscarinic receptor overstimulation affects visceral smooth muscle, cardiac muscle, and secretory glands 1:
Secretory Manifestations
- Excessive salivation
- Lacrimation (tearing)
- Perspiration (secondary to ganglionic stimulation)
- Bronchorrhea (excessive respiratory secretions)
Gastrointestinal Effects
- Nausea and vomiting
- Abdominal cramps
- Severe diarrhea
- Hypermotility
Respiratory Effects
- Bronchospasm
- Laryngeal and upper airway congestion
- Pulmonary edema
Urinary Tract
- Urinary incontinence
Cardiovascular Effects
- Bradycardia (late finding)
- Heart block
- QT prolongation
- Arrhythmias
- Hypotension (follows initial nicotinic hypertension)
The classic mnemonic SLUDGE (Salivation, Lacrimation, Urination, Defecation, Gastric cramps, Emesis) captures the core muscarinic syndrome 2, 3. These symptoms respond to atropine therapy 1.
Nicotinic Symptoms (Neuromuscular Effects)
Nicotinic receptor hyperstimulation affects autonomic ganglia and skeletal muscle 1:
Musculoskeletal Manifestations
- Involuntary fasciculations (early finding)
- Muscle weakness progressing to flaccid paralysis
- Respiratory muscle paralysis (life-threatening)
Cardiovascular Effects (Initial)
- Tachycardia (early sympathetic stimulation)
- Hypertension (precedes muscarinic bradycardia)
Other Nicotinic Effects
The nicotinic effects follow a characteristic progression: fasciculations occur first, followed by complete depolarization block causing weakness and paralysis 1. This sequence is critical because respiratory muscle paralysis is a primary cause of death 1.
Central Nervous System Effects
CNS acetylcholine accumulation produces 1:
- Seizures
- Coma
- Respiratory depression
- Anxiety and disorientation
Clinical Pitfalls and Key Distinctions
A critical caveat: isolated nicotinic symptoms can occur without prominent muscarinic features, particularly in children but rarely in adults 5. This atypical presentation may delay diagnosis if clinicians expect the full SLUDGE syndrome.
The cardiovascular response is biphasic: initial nicotinic sympathetic stimulation causes tachycardia and hypertension, followed by muscarinic-mediated bradycardia and hypotension 1. Recognizing this sequence prevents misinterpretation of early vital signs.
Nicotinic symptoms indicate severe poisoning and typically appear later in the clinical course 6. The presence of fasciculations and muscle weakness signals need for aggressive intervention including oxime therapy (though efficacy remains debated) 1, 7.
Treatment Correlation
The symptom classification directly guides antidotal therapy 1:
- Muscarinic symptoms: Treated with atropine (muscarinic receptor antagonist)
- Nicotinic symptoms: Treated with oximes like pralidoxime (acetylcholinesterase reactivators)
- CNS symptoms: Require benzodiazepines for seizure control
Understanding this receptor-based symptom pattern is essential because atropine only addresses muscarinic manifestations and has no effect on nicotinic-mediated muscle weakness or respiratory paralysis 1, 3. This explains why patients may remain paralyzed despite adequate atropinization.